Toggle navigation
Menu
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
73°
Search
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Local Weather
News
Sports
Entertainment
Calendar
Games
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Town & Gown
Subscribe
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Aptorum Group Ltd Cl A
(NQ:
APM
)
3.450
-0.570 (-14.18%)
Official Closing Price
Updated: 7:59 PM EST, Jan 21, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press releases about Aptorum Group Ltd Cl A
< Previous
1
2
3
Next >
Aptorum Group Receives Clearance from Health Canada to Initiate a Phase 1 Clinical Trial for ALS-4, a Small Molecule Drug for Infections Caused by Staphylococcus aureus including Methicillin-resistant
January 20, 2021
Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) ) (“Aptorum Group” or “Aptorum”), a biopharmaceutical company focused on novel technologies including the targeting of infectious diseases,...
From
Business Wire News Releases
Black & Veatch Sells Data Analytics Solutions Leader Atonix Digital™
January 14, 2021
Tags
APM
Black & Veatch
Industry, Innovation and Infrastructure
From
3BL Media: Corporate Social Responsibility, Energy and Health News
Aptorum Group Announces Submission of Clinical Trial Application for ALS-4, an Orally Administered Small Molecule Drug for the Treatment of Infections caused by Staphylococcus aureus including Methici
December 21, 2020
Regulatory News:
From
Business Wire News Releases
Aptorum Group Limited Announces Results of 2020 Annual General Meeting of Shareholders
December 10, 2020
Regulatory News:
From
Business Wire News Releases
Application Performance Management (APM) Market SWOT Analysis by Key Players Dell Software, Compuware, CA Technologies, BMC Software
December 03, 2020
Edison, NJ -- (SBWIRE) -- 12/03/2020 -- The Application Performance Management (APM) Market study is a perfect mix of qualitative and quantitative information and to get better understanding on how...
From
SBWire - Latest Press Releases
Application Performance Monitoring (APM) Software Market May Set New Growth Story During 2020 to 2025
November 06, 2020
Edison, NJ -- (SBWIRE) -- 11/06/2020 -- Application Performance Monitoring (APM) Software Market Size, Status and Forecast 2020-2025
From
SBWire - Latest Press Releases
Aptorum Group Limited to Hold Annual General Meeting of Shareholders on December 9, 2020
October 16, 2020
Regulatory News:
From
Business Wire News Releases
Aptorum Group Announces Closing of $9.0 Million Public Offering
October 02, 2020
Aptorum Group Limited (Nasdaq:APM, Euronext Paris:APM) (“Aptorum Group” or “Aptorum”), a biopharmaceutical company focused on novel technologies including the targeting of infectious diseases, today...
From
Business Wire News Releases
Aptorum Group Announces Pricing of $9.0 Million Public Offering
September 29, 2020
Regulatory News:
From
Business Wire News Releases
Aptorum Group Launches Infectious Disease Liquid Biopsy Subsidiary Start-up and Exclusively In-licensed from Singapore based Accelerate Technologies To Co-Develop Molecular Based Rapid Pathogen Diagno
September 29, 2020
From
ACN Newswire
Aptorum Group Launches Infectious Disease Liquid Biopsy Subsidiary Start-up and Exclusively In-licensed from Singapore based Accelerate Technologies To Co-Develop Molecular Based Rapid Pathogen Diagno
September 29, 2020
Regulatory News:
From
Business Wire News Releases
Aptorum Group Ltd. (NASDAQ: APM) (Euronext Paris: APM) Featured in Virtual Coverage of The Wall Street Investor Forum
September 09, 2020
From
InvestorBrandNetwork
Aptorum Group to Hold Investor Webinar and Present at The Wall Street Investor Forum on September 10
September 08, 2020
From
ACN Newswire
Aptorum Group Joins the BEAM Alliance To Combat Antimicrobial Resistance
September 08, 2020
From
ACN Newswire
Aptorum Group to Hold Investor Webinar and Present at The Wall Street Investor Forum on September 10
September 08, 2020
Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) (“Aptorum Group” or “Aptorum”), a biopharmaceutical company focused on novel therapeutics including the development of next-generation approach...
From
Business Wire News Releases
Aptorum Group Joins the BEAM Alliance To Combat Antimicrobial Resistance
September 08, 2020
Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) (“Aptorum Group”), a biopharmaceutical company focused on novel therapeutics including the development of next-generation therapeutics targeting...
From
Business Wire News Releases
Aptorum Group Announces Video Update Discussing Positive Data on SACT-1 Against Neuroblastoma and Other Potential Tumor Types
September 02, 2020
Aptorum Group Limited (NASDAQ: APM, Euronext Paris: APM) (“Aptorum Group”), a biopharmaceutical company focused on novel therapeutics including the development of next-generation approach therapeutics...
From
Business Wire News Releases
Aptorum Group Announces Further Positive Data on ALS-4 against MRSA Wound Infection and MRSA Bacteraemia against Linezolid and Vancomycin Respectively in In Vivo Models
September 01, 2020
From
ACN Newswire
Aptorum Group Announces Further Positive Data on SACT-1 Against Neuroblastoma and Other Potential Tumor Types
September 01, 2020
From
ACN Newswire
Aptorum Group Limited Reports Financial Results and Business Update for the Six Months Ended June 30, 2020
September 01, 2020
From
ACN Newswire
Aptorum Group Announces Further Positive Data on SACT-1 Against Neuroblastoma and Other Potential Tumor Types
September 01, 2020
Aptorum Group Limited (NASDAQ: APM, Euronext Paris: APM) (“Aptorum Group”), a biopharmaceutical company focused on the development of novel therapeutics including orphan diseases and oncology...
From
Business Wire News Releases
Aptorum Group Announces Further Positive Data on ALS-4 against MRSA Wound Infection and MRSA Bacteraemia against Linezolid and Vancomycin Respectively in In Vivo Models
September 01, 2020
Aptorum Group Limited (NASDAQ: APM, Euronext Paris: APM) (“Aptorum Group”), a biopharmaceutical company focused on novel therapeutics including the development of next-generation approach therapeutics...
From
Business Wire News Releases
Aptorum Group Limited Reports Financial Results and Business Update for the Six Months Ended June 30, 2020
September 01, 2020
Aptorum Group Limited (NASDAQ: APM, Euronext Paris: APM) (“Aptorum Group” or the “Company”), a biopharmaceutical company focuses on the development of novel therapeutics to address global unmet medical...
From
Business Wire News Releases
Aptorum Group Interview to Air on Bloomberg International on the RedChip Money Report
August 28, 2020
Regulatory News:
From
Business Wire News Releases
Aptorum Group Limited to Present at The LD 500 Virtual Conference
August 26, 2020
From
ACCESSWIRE
Aptorum Group Limited to Present at The LD 500 Virtual Conference and H.C. Wainwright 22nd Annual Global Life Sciences Conference
August 26, 2020
Regulatory News:
From
Business Wire News Releases
Aptorum Group Appoints Dr. Herman Weiss as CEO of microbiome-based platform Claves Life Sciences and Dr. Robbie Majzner as scientific advisor to SACT-1 drug for Neuroblastoma and others
August 20, 2020
Regulatory News:
From
Business Wire News Releases
Aptorum Group Becomes the First Nasdaq Listed Biopharmaceutical Company Admitted to Trading on Euronext Paris Stock Exchange Under the Ticker Symbol APM
July 27, 2020
From
ACN Newswire
Aptorum Group Becomes the First Nasdaq Listed Biopharmaceutical Company Admitted to Trading on Euronext Paris Stock Exchange Under the Ticker Symbol APM
July 24, 2020
Regulatory News:
From
Business Wire News Releases
Aptorum Group Prospectus Receives Approval for Listing on the Euronext Paris Stock Exchange
July 17, 2020
Regulatory News:
From
Business Wire News Releases
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.